Search clinical trials for: 5% albumin

Total 9118 results

Instituto Grifols, S.A.

Completed

Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Spain
Instituto Grifols, S.A.
Grifols Biologicals, LLC

Completed

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)

Alzheimer's Disease

Spain, United States
Instituto Grifols, S.A.

Completed

Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"

Liver Failure | Liver Cirrhosis

Spain
University Hospital, Linkoeping

Completed

Volume Kinetics for Hyperoncotic Albumin in Burn Patients as Well as for Healthy Subjects (VAB)

Burns

Sweden
Region Skane

Completed

The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery (AIR)

Systemic Inflammatory Response Syndrome | Pancreatic Neoplasms | Hypovolemia | Urogenital Neoplasm

Sweden
Joachim Zdolsek

Recruiting

Fluid Challenge and Plasma Volume, During Surgery (FC-VE)

Gynecologic Cancer | Colorectal Cancer | Colorectal Disorders | Urologic Cancer | Benign Neoplasm

Sweden
Vanderbilt University Medical Center

Completed

The Use of Colloid Versus Crystalloid in Post-operative Pediatric Cardiac Patients for Fluid Resuscitation

Cardiac Diseases

United States
Hunter Holmes Mcguire Veteran Affairs Medical Center
Grifols Biologicals, LLC

Recruiting

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement (HEAL-LAST)

Hepatic Encephalopathy | Cirrhosis

United States
Instituto Grifols, S.A.
Hospital Clinic of Barcelona

Completed

Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.

Cirrhosis | Ascites

Spain
University Hospital Inselspital, Berne

Completed

Comparison Between Hyperoncotic and Isooncotic Albumin to Support Blood Loss Replacement (VASCALB)

Blood Loss, Surgical | Fluid Retention

Switzerland
IRCCS Policlinico S. Donato

Completed

Albumin vs. Plasma for PEdiAtric pRiming Trial (APPEAR)

Hemorrhage

Italy
William C. Oliver

Terminated

Lactated Ringer's Versus 5% Human Albumin: Cardiac Surgical Patients

Hemodynamic Stability

United States
The Cleveland Clinic
Fresenius Kabi

Completed

Use of 6% Hydroxyethylstarch (130/0.4) in Cardiac Surgical Patients (SHARP)

Postoperative Kidney Injury

United States
Ottawa Hospital Research Institute
Baxter Healthcare Corporation; Canadian Blood Services

Completed

Fluid Resuscitation in Early Septic Shock (PRECISE)

Sepsis | Septic Shock | Severe Sepsis

Canada
Cairo University

Completed

Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

Anesthesia Morbidity

Egypt
Instituto Grifols, S.A.
Grifols Biologicals, LLC

Completed

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Alzheimer's Disease

Spain, United States
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy of 5% Albumin v/s Plasmalyte in Combination With 20% Albumin for Fluid Resuscitation in Cirrhosis With Sepsis Induced Hypotension

Liver Cirrhosis

India
Kirsten Cleemann Rasmussen

Unknown

The Effect of Human Albumin on Coagulation Competence and Hemorrhage

Hemorrhage; Complicating Delivery, Coagulation Defect

Denmark
Grifols Therapeutics LLC
Grifols Biologicals, LLC

Completed

Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

United States
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Hypoalbuminemia in Burn Patients (Halburns)

Second or Third Degree Burns

Canada
Yonsei University

Completed

The Effect of Balanced Crystalloid Versus 5% Albumin on Endothelial Glycocalyx Degradation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery

Coronary Artery Occlusive Disease(CAOD)

Korea, Republic of
EASL - CLIF Consortium

Terminated

The INFECIR-2 Albumin Prevention Study (INFECIR2)

Pneumonia | Cholangitis | Advanced Chronic Liver Disease | Urinary Infection | Other Bacterial Diseases

Spain
University of Saskatchewan

Withdrawn

Comparison of Priming Constituents in Patients Undergoing CPB Assisted Cardiac Surgery: HES 130/0.4 or Albumin 5%

Coronary Artery Disease | Aortic Valve Disease | Mitral Valve Disease

Canada
Karolinska Institutet

Completed

The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma

Asthma | Allergy | Rhinitis
Lars Olaf Cardell

Completed

Is Intralymphatic Allergen Immunotherapy Effective and Safe?

Allergic Rhinitis Due to Grass Pollen

Sweden
Institute of Liver and Biliary Sciences, India

Completed

Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension

Cirrhosis With Septic Shock

India
Karolinska Institutet
Karolinska University Hospital; Skane University Hospital

Completed

Safety and Efficacy Study of Intralymphatic Allergen-specific Immunotherapy

Allergic Rhinitis

Sweden
King Edward Medical University

Completed

Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.

Burns

Pakistan
Jordi Carratala
Institut d'Investigació Biomèdica de Bellvitge; Instituto de Salud Carlos III

Unknown

Effect of Albumin Administration in Hypoalbuminemic Hospitalized Patients With Community-acquired Pneumonia. (ALBUCAP)

Hypoalbuminemia | Community-acquired Pneumonia

Spain
Medical University of Vienna

Completed

Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients

Systemic Inflammatory Response Syndrome

Austria
Andrew Eisenberger

Terminated

Convalescent Plasma for Early Treatment of COVID-19

COVID-19 | SARS-CoV 2

Brazil
Lars Olaf Cardell

Completed

Follow up Study 5-6 Years After ILIT With 2 Concomitant Allergens, Birch and Grass

Allergic Rhinitis

Sweden
University of Malaya

Unknown

Glycocalyx Levels in Patients Undergoing Pancreatectomy

Pancreatic Cancer | Pancreatectomy | Postoperative Pancreatic Fistula | Endothelial Degeneration

Malaysia
Emory University

Terminated

Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI) (CEASE)

Lung Injury, Acute (ALI) | Respiratory Distress Syndrome, Acute (ARDS)

United States
Second Affiliated Hospital, School of Medicine,...

Completed

Study on Efficacy and Safety of Human Albumin in Burn Shock Recovery

Burns Shock
Grifols Therapeutics LLC
Instituto Grifols, S.A.

Recruiting

Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5% (APACHE)

Acute-On-Chronic Liver Failure

United States, United Kingdom, Spain, Germany, Italy, Belgium, France, Austria, Denmark, Portugal
Sun Yat-sen University

Unknown

Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer

Gastric Caner

China
University of Roma La Sapienza

Completed

Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy

Hepatic Encephalopathy
Medical University of Graz

Active, not recruiting

Effect of Albumin Infusion on Oxidative Albumin Modification, Albumin Binding Capacity and Plasma Thiol Status (ALB-INFUS)

Decompensated Cirrhosis

Austria
Baylor College of Medicine

Terminated

Treatment of Subarachnoid Hemorrhage With Human Albumin (ALISAH)

Subarachnoid Hemorrhage

United States
Jena University Hospital
German Research Foundation; Instituto Grifols, S.A.; University Hospital Goettingen and other collaborators

Recruiting

Albumin Replacement Therapy in Septic Shock (ARISS)

Septic Shock

Germany
Institut Paoli-Calmettes

Unknown

Serum-Ascites Albumin Gradient Analysis in Cancer Patients in Palliative Care (AGASA-SP)

Solid Cancer in a Palliative Situation With Ascites

France
Hainan People's Hospital
Southern Medical University, China

Unknown

Importance of the Infusion Rate for the Plasma Expanding Effect of 5% Albumin in the Septic Patient

Sepsis

China
University of California, San Diego
Grifols Biologicals, LLC

Completed

Fluid Mobilization in Hospitalized Patients With Acute Kidney Injury

Fluid Overload | Hypotension During Dialysis
Fifth Affiliated Hospital, Sun Yat-Sen University
Dongguan People's Hospital

Recruiting

The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC

Head and Neck Squamous Cell Carcinoma | Neoadjuvant Treatment

China
Coretherapix
Hospital General Universitario Gregorio Marañon; Universitaire Ziekenhuizen... and other collaborators

Completed

Safety and Efficacy Evaluation of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With AMI (CAREMI)

Acute Myocardial Infarction

Spain
Protgen Ltd

Completed

Recombinant Human Serum Albumin in Healthy Subjects

Hepatic Ascites

China
Institute of Liver and Biliary Sciences, India

Completed

Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.

Spontaneous Bacterial Peritonitis

India
National Medical Research Center for Rehabilitation...
Pirogov Russian National Research Medical University; DNKOM LLC; The Orenburg...

Recruiting

Study of Efficacy and Safety of the Plasmapheresis Method With Albumin Compensation Compared With the Plasmapheresis Method Without Albumin Compensation for Aging Biomarkers Correction in Men and Women Aged 40 to 55 Years Old

Cardiovascular Diseases | Nervous System Diseases | Urologic Diseases | Diabetes | Neuromuscular Diseases | Hypercholesterolemia | Gout | Hyperbilirubinemia | Hyper IgE Syndrome | Hyper-LDL-cholesterolemia | Hyper Beta Lipoproteinemia | Hyper Eosinophilic Syndrome

Russian Federation
Protgen Ltd

Completed

Phase II/III of Recombinant Human Serum Albumin

Hepatic Ascites

China

Search clinical trials for: 5% albumin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations